Drug Type TCR therapy |
Synonyms- |
Target- |
Mechanism Cell replacements |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Acute Biphenotypic Leukemia | Phase 1 | US | 23 Feb 2018 | |
acute leukemia | Phase 1 | US | 23 Feb 2018 | |
Acute Lymphoblastic Leukemia | Phase 1 | US | 23 Feb 2018 | |
Acute Myeloid Leukemia | Phase 1 | US | 23 Feb 2018 | |
Blast Phase Chronic Granulocytic Leukemia | Phase 1 | US | 23 Feb 2018 | |
Blastic Plasmacytoid Dendritic Cell Neoplasm | Phase 1 | US | 23 Feb 2018 | |
Chronic Myelomonocytic Leukemia | Phase 1 | US | 23 Feb 2018 | |
Chronic phase chronic myeloid leukemia | Phase 1 | US | 23 Feb 2018 | |
Juvenile Myelomonocytic Leukemia | Phase 1 | US | 23 Feb 2018 | |
Mixed phenotype acute leukemia | Phase 1 | US | 23 Feb 2018 |